The syndecan-1 ectodomain regulates αvβ3 integrin activily in human mammary carcinoma cells

Journal of Cell Biology

Volumn 167, Issue 1, 2004, Pages 171-181

  Beauvais, DeannaLee M ^a   Burbach, Brandon J ^a   Rapraeger, Alan C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOSYLPHOSPHATIDYLINOSITOL; GROWTH FACTOR; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; SYNDECAN 1; VITRONECTIN RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL MIGRATION; CELL SPREADING; CELL STRAIN MDA MB 231; CELL STRAIN MDA MB 435; CELL STRUCTURE; CELL SURVIVAL; COMPETITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; MORPHOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SEPARATION; CELL SURVIVAL; FLOW CYTOMETRY; GENE DELETION; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INTEGRIN ALPHAVBETA3; INTEGRINS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SYNDECAN-1; SYNDECANS; VITRONECTIN;

EID: 5444242206     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200404171     Document Type: Article

References (75)

1. Adams, J.C., N. Kureishy, and A.L. Taylor. 2001. A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J. Cell Biol. 152:1169-1182.
2. Akiyama, S.K., S.S. Yamada, W.T. Chen, and K.M. Yamada. 1989. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol. 109:863-875.
3. Barbareschi, M., P. Maisonneuve, D. Aldovini, M.G. Cangi, L. Pecciarini, F. Angelo Mauri, S. Veronese, O. Caffo, A. Lucenti, P.D. Palma, et al. 2003. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer. 98:474-483.
4. 3 integrins in human breast carcinoma cells. Exp. Cell Res. 286:219-232.
5. Beauvais, D.M., and A.C. Rapraeger. 2004. Syndecans in tumor cell adhesion and signaling. Reprod. Biol. Endocrinol. 2:3.
6. Beglova, N., S.C. Blacklow, J. Takagi, and T.A. Springer. 2002. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat. Struct. Biol. 9:282-287.
7. Bernfield, M., M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum, and M. Zako. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:729-777.
8. v integrin cytoplasmic tail. J. Biol. Chem. 271:31458-31462.
9. 3-mediated adhesion to fibronectin versus vitronectin. J. Biol. Chem. 276:31684-31690.
10. 3 integrin through its extracellular domain. J. Biol. Chem. 275:39867-39873,
11. Brooks, P.C., A.M. Montgomery, M. Rosenfeld, R.A. Reisfeld, T. Hu, G. Klier, and D.A. Cheresh. 1994. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164.
12. Burbach, B.J., A. Friedl, C. Mundhenke, and A.C. Rapraeger. 2003. Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol 22:163-177.
13. Calderwood, D.A., R. Zent, R. Grant, D.J. Rees, R.O. Hynes, and M.H. Ginsberg. 1999. The Talin head domain binds to integrin β subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274:28071-28074.
14. Calderwood, D.A., B. Van, J.M. de Pereda, B.G. Alvarez, Y. Fujioka, R.C. Liddington, and M.H. Ginsberg. 2002. The phosphotyrosine binding-like domain of talin activates integrins. J. Biol. Chem. 277:21749-21758.
15. Carey, D.J., R.C. Stahl, G. Cizmeci-Smith, and V.K. Asundi. 1994. Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J. Cell Biol. 124:161-170.
16. Carman, C.V., and T.A. Springer. 2003. Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15:547-556.
17. 1, in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111:2795-2800.
18. Couchman, J.R., L. Chen, and A. Woods. 2001. Syndecans and cell adhesion. Int. Rev. Cytol. 207:113-150.
19. David, G., B. van der Schueren, P. Marynen, J.J. Cassiman, and H. van den Berghe. 1992. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J. Cell Biol. 118:961-969.
20. de Vries, J.E., G.D. Keizer, A.A. te Velde, A. Voordouw, D. Ruiter, P. Rumke, H. Spits, and C.G. Figdor. 1986. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells. Int. J. Cancer. 38:465-473.
21. 3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene. 20:2032-2043.
22. 3 subunit. J. Biol. Chem. 270:26146-26151.
23. Eliceiri, B.P. 2001. Integrin and growth factor receptor crosstalk. Circ. Res. 89:1104-1110.
24. Eliceiri, B.P., R. Klemke, S. Stromblad, and D.A. Cheresh. 1998. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140:1255-1263.
25. Felding-Habermann, B., T.E. O'Toole, J.W. Smith, E. Fransvea, Z.M. Ruggeri, M.H. Ginsberg, P.E. Hughes, N. Pampori, S.J. Shattil, A. Saven, and B.M. Mueller. 2001. Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. USA. 98:1853-1858.
26. 3 by its extracellular domain. J. Biol. Chem. 278:26655-26665.
27. 3 function through integrin-associated protein. J. Cell Biol. 135:533-544.
28. Giancotti, F.G., and E. Ruoslahti. 1999. Integrin signaling. Science. 285:1028-1032.
29. Gonzalez, A.M., M. Gonzales, O.S. Herron, U. Nagavarapu, S.B. Hopkinson, D. Tsuruta, and J.C. Jones. 2002. Complex interactions between the laminin α4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo. Proc. Natl. Acad. Sci. USA. 99:16075-16080.
30. Granes, F., R. Garcia, R.P. Casaroli-Marano, S. Castel, N. Rocamora, M. Reina, J.M. Urena, and S. Vilaro. 1999. Syndecan-2 induces filopodia by active cdc42Hs. Exp. Cell Res. 248:439-456.
31. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 726 pp.
32. Hood, J.D., R. Frausto, W.B. Kiosses, M.A. Schwartz, and D.A. Cheresh. 2003. Differential αv integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J. Cell Biol. 162:933-943.
33. Hughes, P.E., F. Diaz-Gonzalez, L. Leong, C. Wu, J.A. McDonald, S.J. Shattil, and M.H. Ginsberg. 1996. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J. Biol. Chem. 271:6571-6574.
34. Ilic, D., E.A. Almeida, D.D. Schlaepfer, P. Dazin, S. Aizawa, and C.H. Damsky. 1998. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143:547-560.
35. Jalkanen, M., H. Nguyen, A. Rapraeger, N. Kurn, and M. Bernfield. 1985. Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody. J. Cell Biol. 101:976-984.
36. 3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J. Biol. Chem. 273:13878-13885.
37. 3 integrin cytoplasmic tail. J. Cell Biol. 137:1433-1443.
38. 1and protein kinase A. J. Biol. Chem. 275:33920-33928.
39. Kim, Y., H. Park, Y. Lim, I. Man, H.J. Kwon, A. Woods, and E.S. Oh. 2003. Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. Oncogene. 22:826-830.
40. Kiosses, W.B., S.J. Shattil, N. Pampori, and M.A. Schwanz. 2001. Rac recruits high-affinity integrin αvβ3 to lamellipodia in endothelial cell migration. Nat. Cell Biol 3:316-320.
41. Kirsch, T., E. Koyama, M. Liu, E.E. Golub, and M. Pacifici. 2002. Syndecan-3 is a selective regulator of chondrocyte proliferation. J. Biol. Chem. 277:42171-42177.
42. Langford, J.K., M.J. Stanley, D. Cao, and R.D. Sanderson. 1998. Multiple heparan sulfate chains are required for optimal syndecan-1 function. J. Biol. Chem. 273:29965-29971.
43. Law, D.A., F.R. DeGuzman, P. Heiser, K. Ministri-Madrid, N. Killeen, and D.R. Phillips. 1999. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function. Nature. 401:808-811.
44. Lebakken, C.S., and A.C. Rapraeger. 1996. Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells. J. Cell Biol. 132:1209-1221.
45. Lebakken, C.S., K.J. McQuade, and A.C. Rapraeger. 2000. Syndecan-1 signals independently of β1 integrins during Raji cell spreading. Exp. Cell Res. 259:315-325.
46. Liapis, H., A. Flath, and S. Kitazawa. 1996. Integrin αvβ3 expression by bone-residing breast cancer metastases. Diagn. Mol. Pathol. 5:127-135.
47. Lin, B.C., B.I. Ratnikov, P.M. Tsai, E.R. Gonzalez, S. McDonald, A.J. Pelletier, and J.W. Smith. 1997. Evidence that the integrin β3 and β5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain. J. Biol. Chem. 272:14236-14243.
48. Lindberg, P.P., H.D. Gresham, M.I. Reinhold, and E.J. Brown. 1996. Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J. Cell Biol. 134:1313-1322.
49. Liu, W., E.D. Litwack, M.J. Stanley, J.K. Langford, A.D. Lander, and R.D. Sanderson. 1998. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J. Biol. Chem. 273:22825-22832.
50. McFall, A.J., and A.C. Rapraeger. 1997. Identification of an adhesion site within the syndecan-4 extracellular protein domain. J. Biol. Chem. 272:12901-12904.
51. McFall, A.J., and A.C. Rapraeger. 1998. Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4. J. Biol. Chem. 273:28270-28276.
52. McQuade, K.J., and A.C. Rapraeger. 2003. Syndecan-1 transmembrane and extracellular domains have unique and distinct roles in cell spreading. J. Biol. Chem. 278:46607-46615.
53. Mould, A.P., S.K. Akiyama, and M.J. Humphries. 1996. The inhibitory anti-β1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function. J. Biol. Chem. 271:20365-20374.
54. Ohtake, T., Y. Fujimoto, K. Ikuta, H. Saito, M. Ohhira, M. Ono, and Y. Kohgo. 1999. Proiine-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells. Br. J. Cancer. 81:393-403.
55. 3 detected with a novel patch-engineered monovalent ligand. J. Biol. Chem. 274:21609-21616.
56. Park, H., Y. Kim, Y. Lim, I. Han, and E.S. Oh. 2002. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J. Biol. Chem. 277:29730-29736.
57. 3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res. 59:2724-2730.
58. 3 to support tumor cell arrest under dynamic flow conditions. J. Biol. Chem. 277:21930-21938.
59. Rapraeger, A.C. 2000. Syndecan-regulated receptor signaling. J. Cell Biol. 149:995-998.
60. v subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol. Chem. 277:7377-7385.
61. 3 integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signaling. J. Biol. Chem. 273:12623-12632.
62. 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin β3 subunit. J. Cell Biol. 131:807-816.
63. Simon, D.I., Y. Wei, L. Zhang, N.K. Rao, H. Xu, Z. Chen, Q. Liu, S. Rosenberg, and H.A. Chapman. 2000. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275:10228-10234.
64. Smith, J.W. 1997. Allostery and proteolysis: two novel modes of regulating integrin function. Matrix Biol. 16:173-178.
65. 3-integrins. J. Biol. Chem. 269:960-967.
66. Stupack, D.O., X.S. Puente, S. Boutsaboualoy, C.M. Storgard, and D.A. Cheresh. 2001. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155:459-470.
67. Takagi, J., B.M. Petre, T. Walz, and T.A. Springer. 2002. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 110:599-611.
68. Timar, J., A. Ladanyi, K. Lapis, and M. Moczar. 1992. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. Am. J. Pathol. 141:467-474.
69. Tkachenko, E., and M. Simons. 2002. Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J. Biol. Chem. 277:19946-19951.
70. Tumova, S., A. Woods, and J.R. Couchman. 2000. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J. Biol. Chem. 275:9410-9417.
71. van der Flier, A., and A. Sonnenberg. 2001. Function and interactions of integrins. Cell Tissue Res. 305:285-298.
72. Wei, Y., M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science. 273:1551-1555.
73. Wijdenes, J., W.C. Vooijs, C. Clement, J. Post, F. Morard, N. Vita, P. Laurent, R.X. Sun, B. Klein, and J.M. Dore. 1996. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br. J. Haematol. 94:318-323.
74. Xue, W., I. Mizukami, R.F. Todd III, and H.R. Petty. 1997. Urokinase-type plasminogen activator receptors associate with β1 and β3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57:1682-1689.
75. Yamashita, Y., K. Oritani, E.K. Miyoshi, R. Wall, M. Bernfield, and P.W. Kincade. 1999. Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. J. Immunol. 162:5940-5948.